Skip to content

Insider · CIK 0001550395

David Altshuler

officer

Files at VRTX (VERTEX PHARMACEUTICALS INC / MA). First filing Nov 19, 2024, latest May 19, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $6.4M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

VRTX: VERTEX PHARMACEUTICALS INC / MA

VRTXOct 9, 2026 · close 510.08

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
3Weak
VRTXsell 210b5-1
VERTEX PHARMACEUTICALS INC / MA
$22k
52 shares
-0%+10% from low-16% from high
33Weak
VRTXsell 210b5-1
VERTEX PHARMACEUTICALS INC / MA
$1.6M
3,231 shares
-12%+27% from low-3% from high
40Moderate
VRTXsell 310b5-1
VERTEX PHARMACEUTICALS INC / MA
$1.6M
3,231 shares
-11%+26% from low-3% from high
35Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
$1.6M
3,231 shares
-10%+22% from low-6% from high
30Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
$611k
1,272 shares
-4%+20% from low-8% from high
26Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
$408k
848 shares
-2%+21% from low-7% from high
28Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
$533k
1,111 shares
-2%+21% from low-7% from high
10Weak
VRTXsell 310b5-1
VERTEX PHARMACEUTICALS INC / MA
$7,178
15 shares
-0%+4% from low-10% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 15, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-52$424.69$22k23,281May 19, 2025
Mar 13, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-3,231$510.00$1.6M23,281Mar 17, 2025
Mar 10, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-3,231$500.00$1.6M26,512Mar 12, 2025
Mar 3, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-3,231$490.00$1.6M29,743Mar 5, 2025
Feb 26, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
FTax withholding
Common Stock10b5-1
-5,954$479.61$2.9M34,246Feb 28, 2025
Feb 27, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-1,272$480.00$611k32,974Feb 28, 2025
Feb 24, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
FTax withholding
Common Stock10b5-1
-3,971$483.28$1.9M41,048Feb 26, 2025
Feb 25, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-848$480.95$408k40,200Feb 26, 2025
Feb 20, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-1,111$480.00$533k45,019Feb 24, 2025
Feb 14, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
FTax withholding
Common Stock
-2,293$463.46$1.1M46,130Feb 19, 2025
Feb 12, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
AGrant or award
Common Stock
+5,324$0.00$048,423Feb 14, 2025
Feb 10, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
FTax withholding
Common Stock
-2,142$467.98$1.0M43,099Feb 12, 2025
Feb 4, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
AGrant or award
Common Stock
+12,314$0.00$038,127Feb 6, 2025
Feb 4, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
AGrant or award
Common Stock
+7,114$0.00$045,241Feb 6, 2025
Nov 15, 2024VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-15$478.56$7,17825,813Nov 19, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David Altshuler: insider trades and track record | InsiderTell